May 16, 2026 07 Apr 2026 What are the 4 stages of lung cancer? n Medical Review: This article was reviewed by Dr. Sophie Reynolds on April 7, 2026.nnLung cancer staging is a critical step in unde... Continue reading
May 16, 2026 01 Apr 2026 First-Line Palbociclib Combination Boosts PFS in HR+/HER2+ mBC – PATINA Findings n Medical Review: This article was reviewed by Dr. Sophie Reynolds on April 1, 2026.nnMetastatic breast cancer (mBC) remains a major... Continue reading
May 16, 2026 25 Mar 2026 Sunvozertinib vs Chemo: A PFS Breakthrough in EGFR+ NSCLC n Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 25, 2026.nnThe treatment landscape for EGFR-mutated non–... Continue reading
May 16, 2026 23 Mar 2026 Atirmociclib and Fulvestrant Together Delay Cancer Progression in HR+/HER2– Cases Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 23, 2026. Advancements in breast cancer treatment continue t... Continue reading
May 16, 2026 20 Mar 2026 Healing After Radiation: Is a Nipple-Sparing Mastectomy Possible? n Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 20, 2026.nnFor many years, patients who had previously u... Continue reading
May 16, 2026 14 Mar 2026 ESGO 2026 Insights: The Future of Ovarian Cancer Care n Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 14, 2026.nnThe 27th European Congress on Gynaecological ... Continue reading
May 16, 2026 10 Mar 2026 Trifluridine/Tipiracil-Associated Neutropenia in Metastatic Colorectal Cancer: What It Means for Treatment Outcomes n Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 10, 2026.nnMetastatic colorectal cancer (mCRC) remains o... Continue reading
May 17, 2026 05 Mar 2026 New Hope for Advanced Prostate Cancer: Enzalutamide and Radium-223 Combination Shows Survival Benefit n Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 5, 2026.nnAdvances in prostate cancer treatment continue... Continue reading
May 17, 2026 28 Feb 2026 Zongertinib Receives FDA Accelerated Approval for HER2+ NSCLC Treatment n Medical Review: This article was reviewed by Dr. Sophie Reynolds on February 28, 2026.nnThe U.S. Food and Drug Administration has ... Continue reading
May 17, 2026 27 Feb 2026 Targeted Therapy with Larotrectinib in NTRK Fusion Cancers: Results from the NCI-MATCH ECOG-ACRIN Trial n Medical Review: This article was reviewed by Dr. Sophie Reynolds on February 27, 2026.nnPrecision oncology has transformed cancer ... Continue reading